Home / Business and Economy / Torrent Pharma Profit Dips Amidst R&D Spending Surge
Torrent Pharma Profit Dips Amidst R&D Spending Surge
23 Oct
Summary
- Torrent Pharmaceuticals reported a profit decline of nearly 10% in its second quarter.
- Increased research and development expenditures impacted the company's earnings.
- Robust demand for chronic therapies in India partially offset profit reduction.
Torrent Pharmaceuticals reported a notable decrease in its second-quarter profit, with earnings falling by nearly 10%. This financial outcome, announced on Friday, October 23rd, 2026, is attributed to significant investments made in research and development.
These higher expenditures on R&D outpaced the positive impact of strong sales within India. Specifically, the demand for the company's chronic therapies demonstrated robust growth. However, this demand was insufficient to fully counteract the increased operational costs from development initiatives.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
